Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Endostatin plus temozolomide or dacarbazine-based chemotherapy in advanced pNET
NCT01845675Phase 2Completed
- Sponsor
- Peking Union Medical College Hospital
- Start
- Apr 2013
- Primary completion
- Nov 2016
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 2 trial of endostar in Pancreatic neuroendocrine tumor (PanNET), sponsored by Peking Union Medical College Hospital. Started Apr 2013; status: completed.
02
Drugs
endostar
03
Conditions
Pancreatic neuroendocrine tumor (PanNET)
Beyond the preview
Go deeper on NCT01845675.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01845675.